Simon Peter Gampenrieder

Simon Peter Gampenrieder is a Senior Lecturer and Senior physician at the Department of Internal Medicine III, Medical University of Salzburg. His research focuses on medical oncology, particularly breast cancer treatment and therapy development. He has led projects such as the HIT-CIPN trial on chemotherapy-induced neuropathy and contributed to studies on ctDNA monitoring in cancer. His work spans clinical trials, targeted therapies, and translational research.

• Key affiliations: Division of Hematology, Medical Oncology, and Oncologic Center

Research interests include breast cancer screening outcomes, combination therapies, immunotherapy, and genomic approaches to precision medicine. His articles analyze treatment efficacy and biomarker validation in oncology.

He has collaborated on major initiatives like the ABCSG-52 trial and presented on topics like CDK4/6 inhibition and immunotherapy advancements. His work is supported by grants and published in journals like Nature Cancer and Molecular Oncology.